申请人:Mycovia Pharmaceuticals, Inc.
公开号:US10221160B2
公开(公告)日:2019-03-05
The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
本发明描述了具有金属酶调节活性的化合物,以及治疗由此类金属酶介导的疾病、失调或症状的方法。